California Institute for Regenerative Medicine: Accelerating Stem Cell Therapies in California and Beyond

Abstract

[...]we have developed a large network of countries and states in which scientists can apply for research grants together with California scientists. [...]we are creating deeply probing strategies to eradicate those cells in blood cancers and in solid tumors. [...]we have preclinical studies on stroke and ALS using embryonic stem cell derivatives, as well as a study using induced pluripotent stem cells to correct the skin disease known as dystrophic epidermolysis bullosa. The mutated blood stem cells colonized the patient's bone marrow and provided the patient with a blood system completely resistant to HIV infection.